#EBITDA

TITAN Group: Record Year in 2025 with 9.3% EBITDA Increase

Cenergy Targets €400 Million EBITDA by 2026

Lavipharm: Strong EBITDA Growth and Outlook for 2026

BofA Maintains 'Buy' Rating for Metlen with €63 Target Price

Metlen: Strong Growth and Targets for EBITDA Above €1 Billion

Titan: Increased operating profitability with high sales in H1 2025